Zobrazeno 1 - 10
of 34
pro vyhledávání: '"de Jacques Keyser"'
Autor:
van Marc Dijk, Omid S. Eshghi, Maarten Uyttenboogaart, T. Sikkema, Gert-Jan Luijckx, Raf Brouns, de Jacques Keyser
Publikováno v:
European Journal of Neurology. 21(6):820-826
The aim of this narrative review is to evaluate the pathogenesis, clinical features, diagnosis, treatment and prognosis of intracranial artery dissection (IAD). IAD is a rare and often unrecognized cause of stroke or subarachnoid haemorrhage (SAH), e
Autor:
Melissa Cambron, Miguel D'haeseleer, M.J.P. van Osch, Marcus W. Koch, Johannes M. Hoogduin, Y. Fierens, de Jacques Keyser, Christel Steen
Publikováno v:
Acta neurologica Scandinavica, 128(5), E26-E29. Wiley
Acta Neurologica Scandinavica, 128(5), E26-E29
Acta Neurologica Scandinavica, 128(5), E26-E29
BackgroundTo assess the relationship between performance on the Paced Auditory Serial Addition Test (PASAT) and both cerebral blood flow (CBF) and axonal metabolic integrity in normal appearing white matter (NAWM) of the centrum semiovale in patients
Publikováno v:
European Journal of Neurology. 17:1471-1475
Background and purpose: To assess the predictive value of T2 lesions on the rate of progression of disability in multiple sclerosis (MS). Methods: We reanalyzed T2 lesion number and load on brain MRI scans, performed before 1997, of 186 MS patients,
Autor:
Maarten Uyttenboogaart, L A Rödiger, Marcel J. H. Aries, Gert-Jan Luijckx, Patrick C.A.J. Vroomen, K Koopman, de Jacques Keyser
Publikováno v:
JOURNAL OF THE NEUROLOGICAL SCIENCES, 285(1-2), 114-117. ELSEVIER SCIENCE BV
The presence of a hyperdense middle cerebral artery sign (HMCAS) on baseline brain CT is associated with poor clinical outcome in stroke patients treated with intravenous recombinant tissue plasminogen activator (tPA). It remains uncertain whether th
Publikováno v:
Multiple sclerosis journal, 14(6), 799-803. SAGE Publications Inc.
Objective To investigate factors associated with the risk of secondary progression in relapsing-remitting onset multiple sclerosis (MS). Methods We used Kaplan-Meier survival analyses and a multivariable Cox regression model to estimate the influence
Autor:
Patrick C.A.J. Vroomen, Roy E. Stewart, Gert-Jan Luijckx, Maarten Uyttenboogaart, de Jacques Keyser
Publikováno v:
JOURNAL OF THE NEUROLOGICAL SCIENCES, 254(1-2), 28-32. ELSEVIER SCIENCE BV
BACKGROUND: The administration of tissue plasminogen activator (t-PA) has been proven effective for ischemic stroke within 3 h after onset. A pooled-analysis of six trials showed that intravenous t-PA still improves outcome when given between 3 to 4.
Publikováno v:
Acta neurologica Scandinavica, 112(1), 1-5. Wiley
Objectives - The current review evaluates the safety and efficacy of desmopressin in patients with multiple sclerosis (MS) who suffer from both daytime and nocturnal voiding frequency and from incontinence. Materials and methods -A literature search
Autor:
K Koopman, Maarten Uyttenboogaart, Gert-Jan Luijckx, de Jacques Keyser, Patrick C.A.J. Vroomen
Publikováno v:
European Journal of Neurology, 14(10), 1085-1087. Wiley
A case of a 51-year-old woman with reversible cerebral vasoconstriction syndrome (RCVS) without an associative cause is reported. Initially the diagnosis primary angiitis of the central nervous system (PACNS) was considered. Both diagnosis are rare a
Multiple sclerosis and exposure to house pets during childhood and adolescence: a case-control study
Autor:
C Zwanikken, de Jacques Keyser
Publikováno v:
European Journal of Neurology, 4(6), 572-575. Wiley
Scopus-Elsevier
Scopus-Elsevier
Multiple sclerosis (MS) might be triggered by an infectious agent early in life. In a case-control study, we compared exposure to household pets for the age periods 0-5, 6-10, 11-15 and 16-20 years in 100 patients with MS and 100 controls. Exposure t
Publikováno v:
Cerebrovascular Diseases, 29(3), 263-267. KARGER
Background: Preliminary findings suggest that statins may have a neuroprotective effect in patients with acute ischaemic stroke. This study investigated whether patients prior on statin therapy and treated with tissue plasminogen activator (tPA) for
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::02e934760ee9ced878d55370d2ac2a92
https://research.rug.nl/en/publications/6f666575-df9f-408d-a730-41e74d027525
https://research.rug.nl/en/publications/6f666575-df9f-408d-a730-41e74d027525